VitaSpring Biomedical Valuation
| VSBC Stock | USD 1.00 0.00 0.00% |
Today, the company appears to be fairly valued. VitaSpring Biomedical has a current Real Value of $1.0 per share. The regular price of the company is $1.0. Our model measures the value of VitaSpring Biomedical from inspecting the company fundamentals such as Operating Margin of 0.24 %, price to book of 1,622 X, and Return On Equity of 0.84 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that VitaSpring Biomedical's price fluctuation is very steady at this time. Calculation of the real value of VitaSpring Biomedical is based on 3 months time horizon. Increasing VitaSpring Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since VitaSpring Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VitaSpring Pink Sheet. However, VitaSpring Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 1.0 | Hype 1.0 |
The real value of VitaSpring Pink Sheet, also known as its intrinsic value, is the underlying worth of VitaSpring Biomedical Company, which is reflected in its stock price. It is based on VitaSpring Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of VitaSpring Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of VitaSpring Biomedical Co helps investors to forecast how VitaSpring pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VitaSpring Biomedical more accurately as focusing exclusively on VitaSpring Biomedical's fundamentals will not take into account other important factors: About VitaSpring Biomedical Valuation
The pink sheet valuation mechanism determines VitaSpring Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of VitaSpring Biomedical. We calculate exposure to VitaSpring Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VitaSpring Biomedical's related companies.The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California. Vitaspring Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct VitaSpring Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates VitaSpring Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct VitaSpring Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain VitaSpring Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine VitaSpring Biomedical's revenue streams: Identify VitaSpring Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research VitaSpring Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish VitaSpring Biomedical's growth potential: Evaluate VitaSpring Biomedical's management, business model, and growth potential.
- Determine VitaSpring Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate VitaSpring Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
VitaSpring Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 206 M | |
| Quarterly Earnings Growth Y O Y | 0.167 | |
| Retained Earnings | 816.7 K | |
| Retained Earnings Total Equity | -816.7 K |
Complementary Tools for VitaSpring Pink Sheet analysis
When running VitaSpring Biomedical's price analysis, check to measure VitaSpring Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VitaSpring Biomedical is operating at the current time. Most of VitaSpring Biomedical's value examination focuses on studying past and present price action to predict the probability of VitaSpring Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VitaSpring Biomedical's price. Additionally, you may evaluate how the addition of VitaSpring Biomedical to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |